Dry Syrup: A Comprehensive Review
Pharmaceutical Science-Pharmacy
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.P39-46Keywords:
Dry Syrup, Paediatrics, Mixing, Oral Administration, and Blending.Abstract
The oral dosage forms are most popular because of their ease of administration, patient compliance, and formulation stability. Tablets and capsules, the most popular oral dosage form, have the drawback of difficulty swallowing the dosage form specially developed for pediatric and geriatric patients. In recent times the, modern scientific and technological advancement in pharmaceutical field has created a bank of interest in the reconstitutable oral suspension (Dry syrup). Dry syrups are the dry mixtures that require adding water at the dispensing time. Dry syrups show adequate chemical stability of drug during shelf life and reduce the final product's weight. Moreover, dry syrups show higher bioavailability than tablets and capsules as they disintegrate in water outside the oral cavity and directly enter the gastrointestinal tract. Most of the drugs prepared as dry powders for oral suspensions are antibiotics. The present review gives an account of the excipients used, methods of preparation of dry syrup, their evaluation, and their packaging. When manufacturing dry syrup medicine, the dry mixture should have a uniform concentration of the required ingredients. This ensures that the drug does not break up into a non-homogeneous mixture when reconstituted, which may lead to errors in dosage. The items used in the manufacturing of dry syrup include excipients, granule disintegrating, granule binder and powder blends. Excipients are used to stabilize active ingredients for a long period. The type of excipient used is based on the suitability for reconstitution and the type of the powder the granule disintegrate helps ensure the dry syrup particles do not aggregate during reconstitution. The granule binder helps ensure that the dry syrup's particles settle in the suspension.
References
Kundu S, Patil AV, Srinivasan G, Borkar N. Controlled release suspension: a review. Int J Pharm Innov. 2011;2(4):1-18.
Patel M, Patel KR, Patel MR, Patel NM. Formulation and evaluation of microemulsion based gel of ketoconazole. Int J Univers Pharm Bio Sci. 2014;3(2):93-111.
Singh VK, Mishra VK, Maurya JK. Formulation and evaluation of cephalexin monohydrate re-constitutional oral suspension with piperine and their antibacterial activity. World J Pharm Res. 2014;3(5):821-31.
Kumar RS, Yagnesh TNS. Pharmaceutical suspensions: patient compliance oral dosage forms. World J Pharm Pharm Sci. 2016;7(12):1471-537.
Ecanow B. etalii. Newer aspects of suspension theory. Amer. Perfum Cosmet. 1969;84(11):27-30.
Bardeskar C, Geeverghese R. Reconstitutable oral suspensions (dry syrups): an overview. World J Pharm Res. 2014;4(3):462-84.
Damor SR, Jethara SI, Patel MS, Patel MR. A review on dual release oral reconstitutable suspension. World J Pharm Res. 2015;4(3):592-613.
Bhandare PS, Yadav AV. A review on ”dry syrups for paediatrics”. Int J Curr Pharm Res. 2015;9(1):25-31. doi: 10.22159/ijcpr.2017v9i1.16789.
Ofner CM, Schnaare RL, Schwartz JB. Reconstitutable oral suspension. NJ: Corporation; 1984. P. 243-59.
Pavane M, Shirsat M, Dhobale A, Joshi D, Dhembre G, Ingale P. Formulation, development and evaluation of oral reconstitutable dry syrup. Indo Am J Pharm Sci. 2018;5(1):483-91.
Railkar AM, Schwartz JB. Use of a moist granulation technique (MGT) to develop controlled-release dosage forms of acetaminophen. Drug Dev Ind Pharm. 2001;27(4):337-43. doi: 10.1081/DDC-100103733, PMID 11411901.
Pavane M, Shirsat M, Dhobale A, Joshi D, Dhembre G, Ingale P. Formulation, development and evaluation of oral reconstitutable dry syrup. Indo Am J Pharm Sci. 2018;5(1):483-91.
Bhandare PS, Yadav AV. A review on ”dry syrups for paediatrics”. Int J Curr Pharm Res. 2015;9(1):25-31. doi: 10.22159/ijcpr.2017v9i1.16789.
Blasé CM, Shah MN; 1993. Taste-masked pharmaceutical suspensions for pharmaceutical actives. European Patent 0556057.
15. Sayed UG, Bajaj AN. Indian Drugs. 2000 Oral controlled release bromhexine ion-exchange resinate suspension formulation;37:185-9.
Kuksal K, Pathak K16. Use of solubility parameter to design dry suspension of cefaclor as a dual pack system. Ind J Pharm Sci. 2008;70(5):609-13. doi: 10.4103/0250-474X.45399, PMID 21394257.
Bardeskar C, Geeverghese R. Reconstituitable oral suspensions (Dry Syrups): an overview. World J Pharm Res. 2015;4:462-84.5.
Pratik P, Patel MR, Patel KR, Patel NM. A review on taste masking pediatric dry syrup. Int J Univers Pharm Bio Sci. 2013;2;8141:2319.
Indian pharmacopoeia. Vol. II; 2014. p. 952-1057.
European Medicines Agency. ICH Topic Q 6 A Specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical Substances; 2000.
Published
How to Cite
Issue
Section
Copyright (c) 2022 K. Mary Swarnalatha, A. Harshika, V.T. Iswariya, N. Madhavi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

